Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 7/20 | 0.44 |
| ▸ | RAB9A | P51151 | 7/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.44 |
| ▸ | CASP3 | P42574 | 4/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26465659 | 0.91 | SMN1; SMN2 (0.46) | NPC1RAB9ASMN1; SMN2CASP3SENP7 | |
| SCHEMBL26465045 | 0.89 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2CASP3SENP7 | |
| SCHEMBL25818220 | 0.88 | NPC1 (0.38) | NPC1RAB9ASMN1; SMN2CASP3SENP7 | |
| SCHEMBL26465653 | 0.87 | SMN1; SMN2 (0.47) | NPC1RAB9ASMN1; SMN2CASP3SENP7 | |
| SCHEMBL24551665 | 0.87 | KDM4E (0.43) | NPC1RAB9ASMN1; SMN2CASP3SENP7 | |
| SCHEMBL24551821 | 0.85 | SMN1; SMN2 (0.41) | NPC1RAB9ASMN1; SMN2CASP3SENP7 | |
| SCHEMBL24551620 | 0.85 | SMN1; SMN2 (0.41) | NPC1RAB9ASMN1; SMN2CASP3SENP7 | |
| SCHEMBL24550214 | 0.85 | NPC1 (0.47) | NPC1RAB9ASMN1; SMN2CASP3SENP7 | |
| SCHEMBL25732642 | 0.85 | UTRN (0.48) | NPC1RAB9ASMN1; SMN2CASP3SENP7 | |
| SCHEMBL24550219 | 0.85 | SMN1; SMN2 (0.42) | NPC1RAB9ASMN1; SMN2CASP3SENP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11985894-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-05-14 | — | — | US | disclosed |
| US-11985894-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-05-14 | — | — | US | disclosed |
| US-11917914-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-11917914-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-11785847-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11785847-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-20230292612-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230292612-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230276707-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-08-31 | — | — | US | disclosed |
| US-20230276707-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-08-31 | — | — | US | disclosed |
| US-20230225206-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
| US-20230225206-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11785847-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | NFE2L2, ESR1, OR51E2 | NPC1 3164/4885RAB9A 3232/4885SMN1; SMN2 521/4885 |
| US-20230276707-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | NFE2L2, ESR1, OR51E2 | NPC1 3164/4885RAB9A 3232/4885SMN1; SMN2 521/4885 |
| US-11917914-B1 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | NFE2L2, ESR1, OR51E2 | NPC1 3215/4885RAB9A 3347/4885SMN1; SMN2 474/4885 |
| US-11985894-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | NFE2L2, ESR1, OR51E2 | NPC1 3215/4885RAB9A 3347/4885SMN1; SMN2 474/4885 |
| US-20230225206-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | NFE2L2, ESR1, OR51E2 | NPC1 3215/4885RAB9A 3347/4885SMN1; SMN2 474/4885 |
| US-20230292612-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | NFE2L2, ESR1, OR51E2 | NPC1 3224/4885RAB9A 3290/4885SMN1; SMN2 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.